简体中文 | 繁體中文 | English

Press Releases

2023-07-27 12:15 Interactive Brokers Expands Overnight Trading to Over 10,000 US Stocks and ETFs
2023-07-27 10:41 BlackRock and Jio Financial Services Agree to Form Joint Venture to Enter India’s Asset Management Industry
2023-07-27 10:38 Rimini Street Announces Expansion and General Availability of Rimini Manage™ Services for SAP Cloud Products
2023-07-27 10:32 Toshiba Materials’ Major Investment in Second Production Facility Will Boost Silicon Nitride Ball Production
2023-07-27 10:26 AmbioPharm, a Global Peptide CDMO
2023-07-27 02:12 NEE DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL COUNSEL, Encourages NextEra Energy, Inc. Investors with Losses to Secure Counsel Before Important July 25 Deadline in Securities Class Action – NEE, NEE-PR, NEE-PQ
2023-07-26 19:30 Rimini Street Statement on U.S. Federal Court Ruling
2023-07-26 19:21 Aleph Farms Submits First Ever Application for Cultivated Meat in Europe
2023-07-26 19:10 COLOPL Group Company Brilliantcrypto Inc., Reveals “Brilliantcrypto,” The Blockchain Game Which Generates Economic Value in The Metaverse With Digital World Gemstones
2023-07-26 18:18 BAX INVESTOR NEWS: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BAX
2023-07-26 16:59 LRN Report Reveals 2 In 5 Codes of Conduct for the World’s Top Publicly Traded Companies Fall Short
2023-07-26 16:16 Lineage Showcases Commitment to Environmental Stewardship and Corporate Citizenship in Inaugural Sustainability Report
2023-07-26 15:56 New Blue Shift Report From Arthur D. Little Outlines the Transformative Value of the Industrial Metaverse
2023-07-26 11:42 COLOPL Group Blockchain Game Company Brilliantcrypto Forms Global Partnership with Paris Saint-Germain F.C. as Premium Partners
2023-07-26 11:36 China Trading Desk Launches Comprehensive China Travel Dashboard Amid Rising Outbound Travel
2023-07-26 11:32 BaroPace Receives Approval for First-in-Human Clinical Trial
2023-07-25 21:44 Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease
2023-07-25 15:30 LAZR DEADLINE TOMORROW: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Luminar Technologies, Inc. Investors with Losses to Secure Counsel Before Important July 25 Deadline in Securities Class Action – LAZR
2023-07-25 13:50 Sustainable Investments in Colombia: Energy Transition, Food Security, and Social Development Drive High Returns
2023-07-25 13:46 Kenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer Announcement

Business Wire Weibo

Industries

Latest Releases